Diagnosticos da America S.A. Statistics
Diagnosticos da America S.A. (DASA3) Stock Statistics & Valuation Metrics
Total Valuation
Diagnosticos da America S.A. has a market cap or net worth of BRL 4.39B. The enterprise value is BRL 11.51B.
- Market Cap
- BRL 4.39B
- Enterprise Value
- BRL 11.51B
Share Statistics
Diagnosticos da America S.A. has 1,255,007,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,255,007,100
- Owned by Insiders
- ―
- Owned by Institutions
- 0.10%
Financial Efficiency
Diagnosticos da America S.A.’s return on equity (ROE) is -0.17 and return on invested capital (ROIC) is 6.19%.
- Return on Equity (ROE)
- -0.17
- Return on Assets (ROA)
- -0.06
- Return on Invested Capital (ROIC)
- 6.19%
- Return on Capital Employed (ROCE)
- 0.07
- Revenue Per Employee
- 425.46K
- Profits Per Employee
- -43.88K
- Employee Count
- 26,255
- Asset Turnover
- 0.60
- Inventory Turnover
- 40.85
Valuation Ratios
The current PE Ratio of Diagnosticos da America S.A. is -5.32. Diagnosticos da America S.A.’s PEG ratio is -0.29.
- PE Ratio
- -5.32
- PS Ratio
- 0.47
- PB Ratio
- 0.61
- Price to FCF
- 42.45
- Price to Operating Cash Flow
- 11.68
- PEG Ratio
- -0.29
Income Statement
In the last 12 months, Diagnosticos da America S.A. had revenue of 11.17B and earned -1.15B in profits. Earnings per share was -0.92.
- Revenue
- 11.17B
- Gross Profit
- 3.39B
- Operating Income
- 1.01B
- Pretax Income
- -612.76M
- Net Income
- -1.15B
- EBITDA
- 2.04B
- Earnings Per Share (EPS)
- -0.92
Cash Flow
In the last 12 months, operating cash flow was 369.32M and capital expenditures -267.74M, giving a free cash flow of 101.58M billion.
- Operating Cash Flow
- 369.32M
- Free Cash Flow
- 101.58M
- Free Cash Flow per Share
- 0.08
Dividends & Yields
Diagnosticos da America S.A. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 2.32%
- Earnings Yield
- -18.86%
Stock Price Statistics
- Beta
- 2.00
- 52-Week Price Change
- 56.00%
- 50-Day Moving Average
- 3.74
- 200-Day Moving Average
- 3.26
- Relative Strength Index (RSI)
- 48.01
- Average Volume (3m)
- 1.78M
Important Dates
Diagnosticos da America S.A. upcoming earnings date is Mar 31, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 05, 2026
- Next Earnings Date
- Mar 31, 2027
- Ex-Dividend Date
- ―
Financial Position
Diagnosticos da America S.A. as a current ratio of 1.24, with Debt / Equity ratio of 128.79%
- Current Ratio
- 1.24
- Quick Ratio
- 1.20
- Debt to Market Cap
- 1.34
- Net Debt to EBITDA
- 3.03
- Interest Coverage Ratio
- 0.62
Taxes
In the past 12 months, Diagnosticos da America S.A. has paid 521.96M in taxes.
- Income Tax
- 521.96M
- Effective Tax Rate
- -0.85
Enterprise Valuation
Diagnosticos da America S.A. EV to EBITDA ratio is 5.23, with an EV/FCF ratio of 105.43.
- EV to Sales
- 1.17
- EV to EBITDA
- 5.23
- EV to Free Cash Flow
- 105.43
- EV to Operating Cash Flow
- 29.00
Balance Sheet
Diagnosticos da America S.A. has BRL 1.19B in cash and marketable securities with BRL 7.52B in debt, giving a net cash position of -BRL 6.33B billion.
- Cash & Marketable Securities
- BRL 1.19B
- Total Debt
- BRL 7.52B
- Net Cash
- -BRL 6.33B
- Net Cash Per Share
- -BRL 5.05
- Tangible Book Value Per Share
- BRL 2.27
Margins
Gross margin is 29.44%, with operating margin of 11.47%, and net profit margin of -9.04%.
- Gross Margin
- 29.44%
- Operating Margin
- 11.47%
- Pretax Margin
- -6.43%
- Net Profit Margin
- -9.04%
- EBITDA Margin
- 22.43%
- EBIT Margin
- 12.12%
Analyst Forecast
The average price target for Diagnosticos da America S.A. is BRL 2.80, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- BRL 2.80
- Price Target Upside
- 20.23% Downside
- Analyst Consensus
- Neutral
- Analyst Count
- 1
- Revenue Growth Forecast
- -27.40%
- EPS Growth Forecast
- 19.74%

